Current Report Filing (8-k)
May 30 2018 - 5:21PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
May 29, 2018
BIOTECH PRODUCTS SERVICES AND RESEARCH,
INC.
(Exact name of registrant as specified in
its charter)
Nevada
|
|
000-55008
|
|
47-4180540
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No.)
|
4045 Sheridan Avenue, Suite 239
Miami, FL
|
|
33140
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Registrant’s telephone number, including
area code:
(
888) 963-7881
N/A
(Former name or former address, if changed
since last report)
With a copy to:
Richard C. Fox, Esq.
Fox Law Offices, P.A.
561 NE Zebrina Senda
Jensen Beach, FL 34957
T: 772.225.6435
rickfoxesq
@gmail.com
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 29, 2018, Mr. Robert Zucker was appointed
to serve as a member of the Board of Directors of the Company, effective May 29, 2018, for a period of one year, or until the next
annual stockholders’ meeting where his successor is elected and qualified, or his earlier removal.
Business
Experience
Robert W.
Zucker
(age 64) was elected as a member of the Board of Directors of the Company effective May 29, 2018.
Mr. Zucker
is the founder (1993) and currently the managing partner of Zucker Forensics, a firm providing accounting and consulting services
for litigation matters throughout the United States. Mr. Zucker has been qualified as an expert in Miami-Dade, Broward and Palm
Beach Counties, several other State Courts throughout the Country as well as Federal Courts. Mr. Zucker has lectured at various
seminars and possesses over 25 years experience in forensic accounting, tax preparation and has represented over a thousand (1,000)
clients in various litigation matters and acting as an advisor for businesses. Mr. Zucker is a Chartered Global Management Accountant
and a Certified Public Accountant and has received certification in the field of Financial Forensics. Mr. Zucker is also a member
of the American Institute of Certified Public Accountants, Bankruptcy Bar Association Southern District of Florida, the Florida
Institute of Certified Public Accountants and The Florida Bar, Fifteenth Judicial Circuit Grievance Committee “D”.
Mr. Zucker received his BS in Business Administration from Florida Atlantic University, Boca Raton, Florida, in June 1978.
Resignations of Mr. Richard Fox
On May 29, 2018,
Mr. Richard Fox
resigned from the Board of Directors of the Company, creating the vacancy filled by Mr. Zucker.
Item 9.01 Financial Statements and Exhibits.
None.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
BIOTECH PRODUCTS SERVICES AND RESEARCH, INC.
|
|
|
|
Dated: May 30, 2018
|
By:
|
/s/ Manual Iglesias
|
|
|
Manual Iglesias
|
|
|
Chief Executive Officer
|
|
|
(Principal Executive Officer)
|